Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thromboprophylaxis in Patients With COVID-19
Lisa K. Moores, Tobias Tritschler, Shari B. Brosnahan, et al.
CHEST Journal (2022) Vol. 162, Iss. 1, pp. 213-225
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 382
The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury
Mengqi Xiang, Xiaoming Wu, Haijiao Jing, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 38
Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient and post-discharge prophylaxis: a meta-analysis of randomized controlled trials
Jiahao Meng, Hang Tang, Yifan Xiao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH
Alex C. Spyropoulos, Jean M. Connors, James D. Douketis, et al.
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 10, pp. 2226-2236
Open Access | Times Cited: 36
Immuno-Thrombotic Complications of COVID-19: Implications for Timing of Surgery and Anticoagulation
Connor M. Bunch, Ernest E. Moore, Hunter B. Moore, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 35
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment
Luis Ortega‐Paz, Azita H. Talasaz, Parham Sadeghipour, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 08, pp. 816-832
Open Access | Times Cited: 28
COVID-19 associated coagulopathy
Cristian M. Niculae
Elsevier eBooks (2025), pp. 353-367
Closed Access
Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood
Riten Kumar, Michael J. Rivkin, Leslie Raffini
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 9, pp. 2313-2326
Open Access | Times Cited: 13
D-dimer in diagnosis and prevention of venous thrombosis: recent advances and their practical implications
Benilde Cosmi, Cristina Legnani, Alessia Libra, et al.
Polskie Archiwum Medycyny Wewnętrznej (2023)
Open Access | Times Cited: 12
Anticoagulation in hospitalized patients with COVID-19
Lisa Baumann Kreuziger, Michelle Sholzberg, Mary Cushman
Blood (2022) Vol. 140, Iss. 8, pp. 809-814
Open Access | Times Cited: 19
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials
Konstantinos G. Kyriakoulis, Evangelos Dimakakos, Ioannis Kyriakoulis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 5997-5997
Open Access | Times Cited: 19
Effect of anticoagulation on the incidence of venous thromboembolism, major bleeding, and mortality among hospitalized COVID-19 patients: an updated meta-analysis
Xinwang Chen, Suyun Zhang, Haiyu Liu, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Advances and current research in primary thromboprophylaxis to prevent hospital‐associated venous thromboembolism
Lara N. Roberts, Roopen Arya, Beverley J. Hunt
British Journal of Haematology (2024) Vol. 204, Iss. 5, pp. 1635-1648
Closed Access | Times Cited: 2
Role of Therapeutic Anticoagulation in COVID-19: The Current Situation
Mandeep Singh Rahi, Jay Parekh, Prachi Pednekar, et al.
Hematology Reports (2023) Vol. 15, Iss. 2, pp. 358-369
Open Access | Times Cited: 6
Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19
Tatjana Potpara, Dominick J. Angiolillo, Behnood Bikdeli, et al.
CHEST Journal (2023) Vol. 164, Iss. 6, pp. 1531-1550
Open Access | Times Cited: 6
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients
Marina Marchetti, Patricia Gómez-Rosas, Laura Russo, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 10
The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors
Mengqi Xiang, Xiaoming Wu, Haijiao Jing, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Pulmonary thrombosis associated with COVID‐19 pneumonia: Beyond classical pulmonary thromboembolism
Carla Suárez Castillejo, Néstor Calvo, Luminita Preda, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 6
Open Access | Times Cited: 1
POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes
Tobias Tritschler, Grégoire Le Gal, Shari B. Brosnahan, et al.
CHEST Journal (2022) Vol. 161, Iss. 6, pp. 1446-1448
Open Access | Times Cited: 8
Current practices in pediatric hospital‐acquired thromboembolism: Survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium
Christina M Abrams, Julie Jaffray, Amy Stillings, et al.
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 7, pp. e12793-e12793
Open Access | Times Cited: 8
Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art
Evangelos Dimakakos, Georgia Gomatou, M. Catalano, et al.
Anticancer Research (2022) Vol. 42, Iss. 7, pp. 3261-3274
Open Access | Times Cited: 7
Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes
Parham Sadeghipour, Azita H. Talasaz, Stefano Barco, et al.
European Journal of Internal Medicine (2022) Vol. 103, pp. 76-83
Open Access | Times Cited: 6
To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients
Alex C. Spyropoulos
Hematology (2022) Vol. 2022, Iss. 1, pp. 506-514
Open Access | Times Cited: 6
Rivaroxabana em Pacientes Ambulatoriais com COVID-19 Leve ou Moderada: Fundamentação e Desenho do Estudo CARE (CARE – Coalition COVID-19 Brazil VIII)
Gustavo Bernardes de Figueiredo Oliveira, Precil Diego Miranda de Menezes Neves, Haliton Alves de Oliveira, et al.
Arquivos Brasileiros de Cardiologia (2023) Vol. 120, Iss. 3
Open Access | Times Cited: 3
Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study
Pauline Lamouche-Wilquin, Léa Perrin, Morgane Peré, et al.
Thrombosis Journal (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top